Jordi Bruix

Universidad Complutense de Madrid — Spain

Medicine · Health Sciences

128h-index127.4kcitations707works6.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(428), Liver Disease Diagnosis and Treatment(281), Liver Disease and Transplantation(114), Hepatitis B Virus Studies(83), Hepatitis C virus research(72)

Publications704 total

Mesoporous silicon microparticles enhance antiviral immunity and memory responses against SARS-CoV-2
Scientific Reports·2026Open Access
ILT4 and its R20H variant as marker of poor prognosis in Spanish patients with colorectal cancer
Human Immunology·2026Open Access
BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update
Journal of Hepatology·2025· 25 cited
In memoriam: Prof. Jaume Bosch
Journal of Hepatology·2025· 1 citedOpen Access
1501P Early nivolumab addition to regorafenib in patients with hepatocellular carcinoma after first-line therapy (GOING trial)
Annals of Oncology·2025
LBA51 IKF-035/ABC-HCC: A phase IIIb, randomized, multicenter, open-label trial of atezolizumab plus bevacizumab versus transarterial chemoembolization (TACE) in intermediate-stage hepatocellular carcinoma
Annals of Oncology·2025Open Access
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinoma
Journal of Hepatology·2025· 5 citedOpen Access
Disparities in access to systemic therapies for patients with hepatocellular carcinoma: an analysis from the International Liver Cancer Association
The Lancet Regional Health - Europe·2025· 4 citedOpen Access
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
The Lancet·2025· 44 cited
159P ATHECA: Final safety and efficacy analysis of a phase IIIb study of atezolizumab + bevacizumab in Spanish patients with unresectable HCC
Annals of Oncology·2025Open Access
Transarterial chemoembolization with doxorubicin-loaded radiopaque beads for hepatocellular carcinoma: Safety, efficacy, and distribution
Radiología (English Edition)·2025
Recommendations on Perihilar Cholangiocarcinoma. The Milan Jury-Based Consensus
Annals of Surgery·2025· 7 citedOpen Access
WED-136 Proton-pump inhibitors and gut microbiome are associated with survival in patients with hepatocellular carcinoma under immunotherapy
Journal of Hepatology·2025
Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patients
European Radiology·2025· 2 cited
Quimioembolización transarterial con microesferas radiopacas cargadas de doxorrubicina para el carcinoma hepatocelular: seguridad, eficacia y distribución
Radiología·2025
Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
BMC Gastroenterology·2025Open Access
Liver Transplantation for Hepatocellular Carcinoma: An Expanding Cornerstone of Care in the Era of Immunotherapy
Journal of Clinical Oncology·2024· 15 cited
Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study
Drugs - Real World Outcomes·2024Open Access
THU-501 Safety and efficacy preliminary analysis of first-line systemic therapy with atezolizumab plus bevacizumab in Spanish patients with unresectable hepatocellular carcinoma not previously treated with systemic therapy: phase IIIb ATHECA trial
Journal of Hepatology·2024· 1 cited
miRNA Expression and HCC Occurrence in HCV Cirrhotic Patients Treated with Direct Acting Antivirals
Livers·2024Open Access
page 1 of 36Next →

Frequent Co-authors

Josep M. Llovet(35), Vincenzo Mazzaferro(12), Alejandro Forner(10), Myron Schwartz(8), Morris Sherman(8), María Reig(7), Sasan Roayaie(7), Gerold Meinhardt(6), Josep Fuster(5), Carmen Ayuso(5), Concepció Brú(5), María Sala(5), Swan N. Thung(5), R. Vilana(5), Manel Solé(5), Riccardo Lencioni(4), Joan Rodés(4), Yujin Hoshida(4), Augusto Villanueva(4), Judit Peix(4)